ALHC Financials

Income Statement
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025
Revenue
1.3B
+8.2%
1.2B
+25.7%
975.8M
-1.8%
993.7M
-1.2%
1.0B
Cost of Revenue
1.2B
+5.9%
1.1B
+22.6%
889.5M
+2.5%
868.0M
-1.6%
881.7M
Gross Profit
171.9M
+26.6%
135.8M
+57.4%
86.3M
-31.3%
125.7M
+1.0%
124.5M
Operating Expenses
138.9M
+7.7%
129.0M
-3.5%
133.6M
+13.2%
118.0M
+6.5%
110.8M
R&D
0
0
0
0
0
SG&A
131.0M
+8.1%
121.1M
-3.7%
125.8M
+14.3%
110.0M
+6.0%
103.8M
Operating Income
33.1M
+381.5%
6.9M
+114.5%
-47285000
-715.6%
7.7M
-43.8%
13.7M
EBITDA
40.9M
+177.9%
14.7M
+137.3%
-39451000
-350.7%
15.7M
-24.0%
20.7M
Net Income
36.6M
+220.3%
11.4M
+203.7%
-11006000
-395.1%
3.7M
-76.2%
15.7M
EPS (Basic)
$0.18
+200.0%
$0.06
+220.0%
$-0.05
-350.0%
$0.02
-75.0%
$0.08
EPS (Diluted)
$0.17
+240.0%
$0.05
+183.3%
$-0.06
-400.0%
$0.02
-71.4%
$0.07
Shares (Diluted)
215.0M
+0.9%
213.1M
+18.4%
180.0M
-13.9%
208.9M
-0.3%
209.5M
Alignment Healthcare (ALHC) โ€” Financials